Hospital Clinico Universitario Lozano Blesa; Servicio de Oncologia
Zaragoza, Spain
University hospital in Zaragoza
Avda, C. de San Juan Bosco, 15, 50009 Zaragoza
About Hospital Clinico Universitario Lozano Blesa; Servicio de Oncologia
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
13
Puma Biotechnology, Inc.
1
Clinical Trials at Hospital Clinico Universitario Lozano Blesa; Servicio de Oncologia
During the past decade, Hospital Clinico Universitario Lozano Blesa; Servicio de Oncologia conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 7 clinical trials were completed, i.e. on
average, 70% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
2012-05-17
2020-02-19
Completed
2,577
A Study of Pertuzumab in Combination With Trastuzumab (Herceptin) and a Taxane in First-Line Treatment in Participants With Human Epidermal Growth Factor 2 (HER2)-Positive Advanced Breast Cancer
2012-06-01
2019-09-20
Completed
1,436
A Study of Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer Who Have Received Two or More Prior HER2 Directed Regimens in the Metastatic Setting
2013-03-29
2019-12-09
Completed
621
A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor (HER)2 Immunohistochemistry (IHC)-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
2014-12-15
2018-08-20
Completed
49
A Study of Biomarker-Driven Therapy in Metastatic Colorectal Cancer (mCRC)
2015-04-17
2021-03-24
Completed
609
A Study of Atezolizumab (MPDL3280A) Compared With a Platinum Agent (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Participants With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower110]
2015-07-20
2022-03-08
Completed
572
A Study of Carboplatin Plus Etoposide With or Without Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)
2016-06-07
2022-07-07
Completed
403
Study of Atezolizumab as Monotherapy and in Combination With Platinum-Based Chemotherapy in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma
2016-06-30
2023-06-30
Active, not recruiting
1,214
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Clinico Universitario Lozano Blesa; Servicio de Oncologia"
#1 collaborator was "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator and "Institut Jules Bordet/Clinical Trials Support Unit (IJB/CTSU)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Hospital Clinico Universitario Lozano Blesa; Servicio de Oncologia
According to Clinical.Site data, the most researched conditions in "Hospital Clinico Universitario Lozano Blesa; Servicio de Oncologia" are
"Breast Neoplasms" (2 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Non-Small Cell Lung Cancer" (2 trials), "Adenocarcinoma" (1 trials) and "Bronchial Diseases" (1 trials). Many other conditions were trialed in "Hospital Clinico Universitario Lozano Blesa; Servicio de Oncologia" in a lesser frequency.
Clinical Trials Intervention Types at Hospital Clinico Universitario Lozano Blesa; Servicio de Oncologia
Most popular intervention types in "Hospital Clinico Universitario Lozano Blesa; Servicio de Oncologia" are "Drug" (14 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (7 trials), "Carboplatin" (5 trials), "Cisplatin" (3 trials), "Gemcitabine" (3 trials) and "Paclitaxel" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital Clinico Universitario Lozano Blesa; Servicio de Oncologia
The vast majority of trials in "Hospital Clinico Universitario Lozano Blesa; Servicio de Oncologia" are
14 trials for "All" genders.
Clinical Trials Status at Hospital Clinico Universitario Lozano Blesa; Servicio de Oncologia
Currently, there are NaN active trials in "Hospital Clinico Universitario Lozano Blesa; Servicio de Oncologia".
undefined are not yet recruiting,
3 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in Hospital Clinico Universitario Lozano Blesa; Servicio de Oncologia,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hospital Clinico Universitario Lozano Blesa; Servicio de Oncologia, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 10 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".